These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10898035)

  • 1. CT blood pool enhancement in primates with lopromide-carrying liposomes containing soy phosphatidyl glycerol.
    Schmiedl UP; Krause W; Leike J; Sachse A
    Acad Radiol; 1999 Mar; 6(3):164-9. PubMed ID: 10898035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver contrast enhancement in primates using iopromide liposomes.
    Schmiedl UP; Krause W; Leike J; Nelson JA; Schuhmann-Giampieri G
    Acad Radiol; 1995 Nov; 2(11):967-72. PubMed ID: 9419668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood pool and liver enhancement in CT with liposomal lodixanol: comparison with lohexol.
    Desser TS; Rubin DL; Muller H; McIntire GL; Bacon ER; Toner JL
    Acad Radiol; 1999 Mar; 6(3):176-83. PubMed ID: 10898037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodistribution and computed tomography blood-pool imaging properties of polyethylene glycol-coated iopromide-carrying liposomes.
    Sachse A; Leike JU; Schneider T; Wagner SE; Rössling GL; Krause W; Brandl M
    Invest Radiol; 1997 Jan; 32(1):44-50. PubMed ID: 9007647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CT imaging with iopromide liposomes in a rabbit model.
    Krause W; Schönborn A; Rupp K
    J Liposome Res; 2011 Sep; 21(3):229-36. PubMed ID: 21039317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of continuously extruded iopromide-carrying liposomes for computed tomography blood-pool imaging.
    Leike JU; Sachse A; Rupp K
    Invest Radiol; 2001 Jun; 36(6):303-8. PubMed ID: 11410749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast material-carrying liposomes: biodistribution, clearance, and imaging characteristics.
    Seltzer SE; Blau M; Herman LW; Hooshmand RL; Herman LA; Adams DF; Minchey SR; Janoff AS
    Radiology; 1995 Mar; 194(3):775-81. PubMed ID: 7862978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and evaluation of lyophilized iopromide-carrying liposomes for liver tumor detection.
    Sachse A; Leike JU; Rössling GL; Wagner SE; Krause W
    Invest Radiol; 1993 Sep; 28(9):838-44. PubMed ID: 8225891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-residence-time nano-scale liposomal iohexol for X-ray-based blood pool imaging.
    Kao CY; Hoffman EA; Beck KC; Bellamkonda RV; Annapragada AV
    Acad Radiol; 2003 May; 10(5):475-83. PubMed ID: 12755534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of the iodine-free computed tomography liver contrast agent, Dy-EOB-DTPA, in comparison with a conventional iodinated agent in normal and in tumor-bearing rabbits.
    Krause W; Handreke K; Schuhmann-Giampieri G; Rupp K
    Invest Radiol; 2002 May; 37(5):241-7. PubMed ID: 11979149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1-molar gadobutrol as a contrast agent for computed tomography: results from a comparative porcine study.
    Kalinowski M; Kress O; Wels T; Alfke H; Klose KJ; Wagner HJ
    Invest Radiol; 2003 Apr; 38(4):193-9. PubMed ID: 12649642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid-based blood-pool CT imaging of the liver.
    Weichert JP; Lee FT; Longino MA; Chosy SG; Counsell RE
    Acad Radiol; 1998 Apr; 5 Suppl 1():S16-9; discussion S28-30. PubMed ID: 9561034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined hepatocyte-selective and blood-pool contrast agents for the CT detection of experimental liver tumors in rabbits.
    Weichert JP; Lee FT; Chosy SG; Longino MA; Kuhlman JE; Heisey DM; Leverson GE
    Radiology; 2000 Sep; 216(3):865-71. PubMed ID: 10966724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved visualization of vessels and hepatic tumors by micro-computed tomography (CT) using iodinated liposomes.
    Montet X; Pastor CM; Vallée JP; Becker CD; Geissbuhler A; Morel DR; Meda P
    Invest Radiol; 2007 Sep; 42(9):652-8. PubMed ID: 17700281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of iopromide liposomes.
    Krause W; Leike J; Sachse A; Schuhmann-Giampieri G
    Invest Radiol; 1993 Nov; 28(11):1028-32. PubMed ID: 8276573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging characteristics of DHOG, a hepatobiliary contrast agent for preclinical microCT in mice.
    Henning T; Weber AW; Bauer JS; Meier R; Carlsen JM; Sutton EJ; Prevrhal S; Ziegler SI; Feussner H; Daldrup-Link HE; Rummeny EJ
    Acad Radiol; 2008 Mar; 15(3):342-9. PubMed ID: 18280932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helical CT of the liver: evaluation of injection flow rate, mode, and scan delay with a reduced-volume contrast medium bolus.
    Kopka L; Funke M; Vosshenrich R; Hagemann A; Oestmann JW; Grabbe E
    J Comput Assist Tomogr; 1995; 19(3):406-11. PubMed ID: 7790550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body surface area adapted iopromide 300 mg/ml versus 370 mg/ml contrast medium injection protocol: influence on quantitative and clinical assessment in combined PET/CT.
    Verburg FA; Apitzsch J; Lensing C; Kuhl CK; Pietsch H; Mottaghy FM; Behrendt FF
    Eur J Radiol; 2013 Dec; 82(12):2348-52. PubMed ID: 24113432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of pharmacokinetics to electron-beam tomography of the abdomen.
    Krause W; Gröll R; Kern R; Baumgartner C; Rienmüller R
    Acad Radiol; 1999 Aug; 6(8):487-95. PubMed ID: 10480045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iopromide-carrying liposomes as a contrast agent for the liver.
    Krause W; Leike J; Schuhmann-Giampieri G; Sachse A; Schmiedl U; Strunk H
    Acad Radiol; 1996 Aug; 3 Suppl 2():S235-7. PubMed ID: 8796571
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.